Julieta Afonso Selected Research

AZD3965

12/2021	In Vivo Anticancer Activity of AZD3965: A Systematic Review.
6/2019	Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julieta Afonso Research Topics

Disease

7	Neoplasms (Cancer) 12/2021 - 11/2015
4	Carcinoma (Carcinomatosis) 01/2020 - 08/2009
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 08/2009
2	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2013
1	Acidosis 01/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2019
1	Lymphoma (Lymphomas) 06/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2019

Drug/Important Bio-Agent (IBA)

4	Lactic Acid (Lactate)FDA LinkGeneric 12/2021 - 06/2019
3	PlatinumIBA 01/2020 - 11/2015
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 06/2019
2	AZD3965IBA 12/2021 - 06/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2019
1	Oxygen (Dioxygen)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 11/2015
1	Proteins (Proteins, Gene)FDA Link 04/2013
1	raf KinasesIBA 04/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2009
1	Vascular Endothelial Growth Factor CIBA 11/2009
1	AntibodiesIBA 11/2009
1	Sirolimus (Rapamycin)FDA Link 08/2009

Therapy/Procedure

3	Therapeutics 12/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2016 - 11/2015
1	Immunotherapy 01/2020
1	Cystectomy 11/2009